Follow
Gautier Stoll
Gautier Stoll
INSERM U1138, Université Paris Descartes, Gustave Roussy
Verified email at upmc.fr
Title
Cited by
Cited by
Year
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ...
Science 350 (6263), 972-978, 2015
4382015
A new correlation‐based fuzzy logic clustering algorithm for FMRI
X Golay, S Kollias, G Stoll, D Meier, A Valavanis, P Boesiger
Magnetic resonance in medicine 40 (2), 249-260, 1998
3571998
Molecular dynamics simulations of the 136 unique tetranucleotide sequences of DNA oligonucleotides. I. Research design and results on d (CpG) steps
DL Beveridge, G Barreiro, KS Byun, DA Case, TE Cheatham, SB Dixit, ...
Biophysical journal 87 (6), 3799-3813, 2004
3192004
Calculation of long-distance effects in exclusive weak radiative decays of B-mesons
A Khodjamirian, G Stoll, D Wyler
Physics Letters B 358 (1-2), 129-138, 1995
2261995
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
N Jacquelot, T Yamazaki, MP Roberti, CPM Duong, MC Andrews, ...
Cell research 29 (10), 846-861, 2019
1992019
QCD estimate of the long-distance effect in B→ K∗ γ
A Khodjamirian, R Rückl, G Stoll, D Wyler
Physics Letters B 402 (1-2), 167-177, 1997
1661997
Oxidative phosphorylation as a potential therapeutic target for cancer therapy
V Sica, JM Bravo‐San Pedro, G Stoll, G Kroemer
International journal of cancer 146 (1), 10-17, 2020
1612020
CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy
Y Ma, SR Mattarollo, S Adjemian, H Yang, L Aymeric, D Hannani, ...
Cancer research 74 (2), 436-445, 2014
1382014
Continuous time Boolean modeling for biological signaling: application of Gillespie algorithm
G Stoll, E Viara, E Barillot, L Calzone
BMC systems biology 6, 1-18, 2012
1242012
Pro-necrotic molecules impact local immunosurveillance in human breast cancer
G Stoll, Y Ma, H Yang, O Kepp, L Zitvogel, G Kroemer
Oncoimmunology 6 (4), e1299302, 2017
1172017
MaBoSS 2.0: an environment for stochastic Boolean modeling
G Stoll, B Caron, E Viara, A Dugourd, A Zinovyev, A Naldi, G Kroemer, ...
Bioinformatics 33 (14), 2226-2228, 2017
1162017
PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling
G Letort, A Montagud, G Stoll, R Heiland, E Barillot, P Macklin, A Zinovyev, ...
Bioinformatics 35 (7), 1188-1196, 2019
1092019
Immunogenic stress and death of cancer cells: contribution of antigenicity vs adjuvanticity to immunosurveillance
N Bloy, P Garcia, CM Laumont, JM Pitt, A Sistigu, G Stoll, T Yamazaki, ...
Immunological reviews 280 (1), 165-174, 2017
962017
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
A Tosco, F De Gregorio, S Esposito, D De Stefano, I Sana, E Ferrari, ...
Cell Death & Differentiation 23 (8), 1380-1393, 2016
942016
The CoLoMoTo interactive notebook: accessible and reproducible computational analyses for qualitative biological networks
A Naldi, C Hernandez, N Levy, G Stoll, PT Monteiro, C Chaouiya, ...
Frontiers in physiology 9, 680, 2018
922018
Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
G Stoll, D Enot, B Mlecnik, J Galon, L Zitvogel, G Kroemer
Oncoimmunology 3 (3), e27884, 2014
912014
On the parameterization of rigid base and basepair models of DNA from molecular dynamics simulations
F Lankaš, O Gonzalez, LM Heffler, G Stoll, M Moakher, JH Maddocks
Physical Chemistry Chemical Physics 11 (45), 10565-10588, 2009
862009
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
A Buqué, N Bloy, M Perez-Lanzón, K Iribarren, J Humeau, JG Pol, ...
Nature Communications 11 (1), 3819, 2020
842020
AIF-regulated oxidative phosphorylation supports lung cancer development
S Rao, L Mondragón, B Pranjic, T Hanada, G Stoll, T Köcher, P Zhang, ...
Cell research 29 (7), 579-591, 2019
732019
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
JG Pol, SA Acuna, B Yadollahi, N Tang, KB Stephenson, MJ Atherton, ...
Oncoimmunology 8 (1), e1512329, 2019
712019
The system can't perform the operation now. Try again later.
Articles 1–20